Xponance’s BioCryst Pharmaceuticals BCRX Stock Holding History

Xponance’s Portfolio BCRX Stock Details BCRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$201K	Sell	21,137 -1,121	-5%	-$8.71K	﹤0.01%	1475
2025 Q4	$174K	Buy	22,258 +94	+0.4%	+$680	﹤0.01%	1411
2025 Q3	$168K	Buy	22,164 +248	+1%	+$2.06K	﹤0.01%	1384
2025 Q2	$196K	Buy	21,916 +6,349	+41%	+$59.1K	﹤0.01%	1335
2025 Q1	$117K	Buy	15,567 +671	+5%	+$5.41K	﹤0.01%	1327
2024 Q4	$112K	Buy	14,896 +1,242	+9%	+$9.43K	﹤0.01%	1350
2024 Q3	$104K	Buy	13,654 +674	+5%	+$5.12K	﹤0.01%	1317
2024 Q2	$80.2K	Buy	12,980 +1,505	+13%	+$8.3K	﹤0.01%	1257
2024 Q1	$58.3K	Buy	11,475 +94	+0.8%	+$529	﹤0.01%	1269
2023 Q4	$68.2K	Buy	11,381 +182	+2%	+$1.05K	﹤0.01%	1225
2023 Q3	$79.3K	Buy	11,199 +105	+0.9%	+$754	﹤0.01%	1177
2023 Q2	$78.1K	Buy	11,094 +487	+5%	+$3.91K	﹤0.01%	1207
2023 Q1	$88.5K	Hold	10,607	–	–	﹤0.01%	1164
2022 Q4	$122K	Buy	10,607 +163	+2%	+$2.03K	﹤0.01%	1145
2022 Q3	$132K	Buy	10,444 +370	+4%	+$4.76K	﹤0.01%	1106
2022 Q2	$107K	Buy	+10,074	New	+$104K	﹤0.01%	1124

Other funds holding BCRX

BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return

Janus Henderson Group

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Perceptive Advisors New York $5.06B AUM 314.02% 1-Year Est. Return

Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return